OrthoPediatrics Corp KIDS.OQ KIDS.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025
The Warsaw Indiana Indiana-based company is expected to report a 15.7% increase in revenue to $51.683 million from $44.69 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for OrthoPediatrics Corp is for a loss of 45 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OrthoPediatrics Corp is $38.00, above its last closing price of $21.40.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.33
-0.31
-0.69
Missed
-120.2
Sep. 30 2024
-0.22
-0.24
-0.34
Missed
-41.1
Jun. 30 2024
-0.26
-0.27
-0.26
Beat
5.1
Mar. 31 2024
-0.41
-0.40
-0.34
Beat
15.9
Dec. 31 2023
-0.28
-0.28
-0.29
Missed
-3.4
Sep. 30 2023
-0.23
-0.23
-0.20
Beat
10.3
Jun. 30 2023
-0.20
-0.22
-0.13
Beat
39.9
Mar. 31 2023
-0.37
-0.36
-0.30
Beat
17.8
This summary was machine generated May 5 at 20:54 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)